Evidence map›Paper›PMID 31189583›Full record

ArticleJournal of clinical microbiology2019

Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.

Sergi Hernández, Carmen Muñoz-Almagro, Pilar Ciruela, Núria Soldevila, Conchita Izquierdo, Maria Gemma Codina, Alvaro Díaz, Fernando Moraga-Llop, Juan José García-García, Ángela Domínguez

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Altered Signal Transduction in the Immune Response to Influenza Virus andInternational journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sergi HernándezAgència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.ORCID 0000-0002-0461-6190
Carmen Muñoz-AlmagroCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Pilar CiruelaAgència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.
Núria SoldevilaCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Conchita IzquierdoAgència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.
Maria Gemma CodinaHospital Universitari Vall d'Hebron, Barcelona, Spain.
Alvaro DíazHospital de Nens, Barcelona, Spain.
Fernando Moraga-LlopHospital Universitari Vall d'Hebron, Barcelona, Spain.
Juan José García-GarcíaCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Ángela DomínguezDepartament de Medicina, Universitat de Barcelona, Barcelona, Spain.
Generalitat de Catalunya · ESHospital Sant Joan de Déu Barcelona · ESInstituto de Salud Carlos III · ESVall d'Hebron Hospital Universitari · ESHospital de Nens de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of

Indexed as

Severity of Illness IndexAdolescentChildChild, PreschoolFemaleHospitalizationHumansIncidenceInfantInfluenza, HumanMalePandemicsPneumococcal InfectionsPneumococcal VaccinesProspective StudiesSerogroup13-valent pneumococcal vaccinePneumococcal Vaccines13-valent pneumococcal conjugate vaccinehighly invasive serotypesinfluenza virusinvasive pneumococcal diseaseseasonality

Identifiers

PMID31189583
PMCPMC6663900
OpenAlexW2952901733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.